Y-mAbs Therapeutics, Inc. - 984241109
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q3 2025
· Q2 2025
Value (USD)
Total reported value ($000)
$786K
QoQ value delta ($000)
-$116.7M
(-99.33%)
Implied price effect (QoQ)
+0.2%
Shares
Total shares
173,990
QoQ shares delta
-25,882,692
(-99.33%)
Total shares held by funds (by quarter)
Top holders (Q3 2025)
Top 25 only
Full list
Partial Q3 2025 data: 2 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| JACOBS LEVY EQUITY MANAGEMENT, INC | 643 | 142,641 | 0.0% |
| Brooklyn Investment Group | 75 | 16,061 | 0.01% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 59 | 13,143 | 0.0% |
| ROYAL BANK OF CANADA | 7 | 1,612 | 0.0% |
| IFP Advisors, Inc | 2 | 332 | 0.0% |
| Allworth Financial LP | 0 | 201 | 0.0% |